Incyte (INCY) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Incyte (INCY)

INCY 108.15

+2.1%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: LLCF who wrote (1746)	4/26/2001 2:41:22 PM
From: RCMac	Read Replies (2) of 3202

Motley Fool belatedly works out that INCY might have a more attractive business plan than CRA: fool.com Excerpt: "In short, here's what Celera asks investors to believe: That it's somehow got better drug discovery and development information and tools, will extract better and bigger deals from big pharma, and will make more money on its own than companies like Incyte and HGS that are years ahead in the same game." More importantly, there is a link to a February interview with INCY CEO Roy Whitfield (which I believe was discussed here earlier). Maybe Motley Fool is the reason for the 12% rise in INCY so far today? Motley Fool's raving about CRA in December(?), 1999 was one thing that set off the genomics stocks mania of the first quarter last year. --RCM

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next